T

Touchlight

144 employees

Touchlight Genetics develops a DNA production platform designed for the development of DNA vaccines for oncology and infectious diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Contract manufacturing
Oncology
DNA vaccines
DNA amplification
mRNA
Enzymatic technology
Lentivirus
Genetic Medicine
DNA vectors
Innovation
Health Care
Infectious diseases
AAV
DNA
enzymatic DNA
synthetic DNA
Medical
Genome editing
Biopharma
CDMO
Gene therapy
DNA therapeutics

Date founded

2008

Funding rounds raised

Total raised

$2.4M

from 2 investors over 2 rounds

T

Touchlight raised $2.4M on November 28, 2022

Investors: Bill & Melinda Gates Foundation

T

Touchlight raised undisclosed on December 12, 2017

Investors: Innovate UK

FAQ